Sotagliflozin could be used to reduce the risk of deadly cardiovascular events, trial shows
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
Tag: Cardiology
Study finds global underuse of medications for cardiovascular disease prevention
Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to increase their use are needed to ...
Researchers identify key mechanisms behind heart disease in type 2 diabetes
People with type 2 diabetes have a higher risk of developing cardiovascular disease and dying prematurely due to atherosclerosis. A ...
Cryoablation for PFO closure in AF patients undergoing PVI
New research shows that cryoablation is a safe and effective approach to close congenital patent foramen ovale (PFO, a small ...
AI-powered ECG model predicts heart disease risk with precision
Developed using data from diverse patient groups, AIRE’s advanced AI predicts heart disease risk and mortality with precision, giving clinicians ...
SCAI publishes comprehensive guidelines for STEMI treatment
The Society for Cardiovascular Angiography & Interventions (SCAI) is pleased to announce the publication of the Expert Consensus Statement on the ...
COVID-19 found to increase heart attack and stroke risks
An analysis of data in the UK Biobank has found that COVID-19 infection may increase the risk of heart attack, ...
Regular mobile phone use linked to increased cardiovascular disease risk in smokers and diabetics
A new study has found that regular mobile phone use was positively associated with incident cardiovascular diseases risk, especially in ...
FINEARTS-HF trial shows finerenone benefits for heart failure with preserved ejection fraction
Finerenone reduced heart failure (HF) events and cardiovascular death in patients with HF and mildly reduced (HFmrEF) or preserved ejection ...
Mass screening for atrial fibrillation with ECG and biomarker fails to prevent stroke in older adults
Mass screening for atrial fibrillation using ECG together with heart failure biomarker does not prevent ischaemic stroke or systemic embolism ...
